[1]
Mahdi, Z. and Kammas, Z.D. 2026. Network Pharmacology Analysis Predicts that Borago Officinalis Constituents May Influence STING/TBK1/IRF3 Immune Signalling in Non-Small Cell Lung Cancer. American Journal of Medicine and Health Care. 1, 2 (Oct. 2026), 105–111. DOI:https://doi.org/10.54536/ajmhc.v1i2.6726.